Exam (elaborations)

LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE 4TH EDITION BY KARA SEALOCK|| COMPLETE TEST BANK GUIDE|| VERIFIED CHAPTERS INCLUDED WITH ACCURATE & ELABORATED ANSWERS|| NEWEST UPDATE|| 100% GURANTEED GUIDE

2 views 0 purchase

Course
LILLEY\\\'S PHARMACOLOGY FOR CANADIAN HEALTH CARE

Institution
LILLEY\\\'S PHARMACOLOGY FOR CANADIAN HEALTH CARE

Book
Lilley\'s Pharmacology for Canadian Health Care Practice - E-Book

[Show more]

Preview 6 out of 277 pages

View example

Uploaded on January 17, 2025
Number of pages 277
Written in 2024/2025
Type Exam (elaborations)
Contains Questions & answers

lilleys pharmacology
4th edition
pharmacology for canadian health care
canadian health care practice

Book Title:Lilley\'s Pharmacology for Canadian Health Care Practice - E-Book

Author(s):Kara Sealock, Cydnee Seneviratne, Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder

Edition:2020
ISBN:9780323694810
Edition:Unknown

Exam (elaborations)
PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE 4TH EDITION LILLEY’S TEST BANK/ALL CHS 1-58
Exam (elaborations)
TEST BANK Lilleys Pharmacology for Canadian Health Care Practice (4TH) by Sealock Chapter 1-58 Updated Questions & Answers with Rationale
Exam (elaborations)
TEST BANK Lilleys Pharmacology for Canadian Health Care Practice (4TH) by Sealock Chapter 1-58 Updated Questions & Answers with Rationale

Institution LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE
Course LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE

NurseJanetteRichardson

Member since 6 months 56 documents sold

CA$27.60

Add to cart

Add to wishlist

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE 4TH EDITION
BY KARA SEALOCK|| COMPLETE TEST BANK GUIDE|| VERIFIED CHAPTERS
INCLUDED WITH ACCURATE & ELABORATED ANSWERS|| NEWEST UPDATE||
100% GURANTEED GUIDE

,Table of Contents
PART 1. PHARMACOLOGY BASICS ............................................................................................................... 4
CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY .................................................... 4
CHAPTER 02: PHARMACOLOGICAL PRINCIPLES ...................................................................................... 8
CHAPTER 03: LEGAL AND ETHICAL CONSIDERATIONS .......................................................................... 13
CHAPTER 04: PATIENT-FOCUSED CONSIDERATIONS............................................................................. 18
CHAPTER 05: GENE THERAPY AND PHARMACOGENOMICS ................................................................. 26
CHAPTER 06: MEDICATION ERRORS: PREVENTING AND RESPONDING ............................................... 28
CHAPTER 07: PATIENT EDUCATION AND DRUG THERAPY .................................................................... 31
CHAPTER 08: OVER-THE-COUNTER DRUGS AND NATURAL HEALTH PRODUCTS ................................. 35
CHAPTER 09: VITAMINS AND MINERALS ............................................................................................... 39
CHAPTER 10: PRINCIPLES OF DRUG ADMINISTRATION ........................................................................ 43
PART 2. DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM ................................................................. 52
CHAPTER 11: ANALGESIC DRUGS ........................................................................................................... 52
CHAPTER 12: GENERAL AND LOCAL ANAESTHETICS ............................................................................. 58
CHAPTER 13: CENTRAL NERVOUS SYSTEM DEPRESSANTS AND MUSCLE RELAXANTS ........................ 62
CHAPTER 14: CENTRAL NERVOUS SYSTEM STIMULANTS AND RELATED DRUGS................................. 67
CHAPTER 15: ANTIEPILEPTIC DRUGS ..................................................................................................... 72
CHAPTER 16: ANTIPARKINSONIAN DRUGS ........................................................................................... 76
CHAPTER 17: PSYCHOTHERAPEUTIC DRUGS ......................................................................................... 81
CHAPTER 18: SUBSTANCE MISUSE ......................................................................................................... 87
PART 3. DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM .......................................................... 92
CHAPTER 19: ADRENERGIC DRUGS ........................................................................................................ 92
CHAPTER 20: ADRENERGIC-BLOCKING DRUGS ..................................................................................... 97
CHAPTER 21: CHOLINERGIC DRUGS ..................................................................................................... 102
CHAPTER 22: CHOLINERGIC-BLOCKING DRUGS................................................................................... 106
PART 4. DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS .......................................... 111
CHAPTER 23: ANTIHYPERTENSIVE DRUGS ........................................................................................... 111
CHAPTER 24: ANTIANGINAL DRUGS .................................................................................................... 116
CHAPTER 25: HEART FAILURE DRUGS .................................................................................................. 121
CHAPTER 26: ANTIDYSRHYTHMIC DRUGS ........................................................................................... 126
CHAPTER 27: COAGULATION MODIFIER DRUGS ................................................................................. 131
CHAPTER 28: ANTILIPEMIC DRUGS ...................................................................................................... 136

, CHAPTER 29: DIURETIC DRUGS ............................................................................................................ 142
CHAPTER 30: FLUIDS AND ELECTROLYTES ........................................................................................... 147
PART 5. DRUGS AFFECTING THE ENDOCRINE SYSTEM ............................................................................ 152
CHAPTER 31: PITUITARY DRUGS .......................................................................................................... 152
CHAPTER 32: THYROID AND ANTITHYROID DRUGS ............................................................................ 156
CHAPTER 33: ANTIDIABETIC DRUGS .................................................................................................... 161
CHAPTER 34: ADRENAL DRUGS............................................................................................................ 168
CHAPTER 35: WOMEN’S HEALTH DRUGS ............................................................................................ 172
CHAPTER 36: MEN’S HEALTH DRUGS................................................................................................... 179
PART 6. DRUGS AFFECTING THE RESPIRATORY SYSTEM ........................................................................ 184
CHAPTER 37: ANTIHISTAMINES, DECONGESTANTS, ANTITUSSIVES, AND EXPECTORANTS .............. 184
CHAPTER 38: RESPIRATORY DRUGS..................................................................................................... 188
PART 7. DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION .................................. 193
CHAPTER 39: ACID-CONTROLLING DRUGS .......................................................................................... 193
CHAPTER 40: ANTIDIARRHEAL DRUGS AND LAXATIVES ..................................................................... 198
CHAPTER 41: ANTIEMETIC AND ANTINAUSEA DRUGS........................................................................ 203
CHAPTER 42: NUTRITIONAL SUPPLEMENTS ........................................................................................ 207
PART 8. ANTI-INFECTIVE AND ANTI-INFLAMMATORY DRUGS ............................................................... 211
CHAPTER 43: ANTIBIOTICS PART 1: SULFONAMIDES, PENICILLINS, CEPHALOSPORINS, MACROLIDES,
AND TETRACYCLINES ............................................................................................................................ 211
CHAPTER 44: ANTIBIOTICS PART 2: AMINOGLYCOSIDES, FLUOROQUINOLONES, AND OTHER DRUGS
.............................................................................................................................................................. 215
CHAPTER 45: ANTIVIRAL DRUGS.......................................................................................................... 219
CHAPTER 46: ANTITUBERCULAR DRUGS ............................................................................................. 225
CHAPTER 47: ANTIFUNGAL DRUGS ...................................................................................................... 229
CHAPTER 48: ANTIMALARIAL, ANTIPROTOZOAL, AND ANTHELMINTIC DRUGS ................................ 234
CHAPTER 49: ANTI-INFLAMMATORY AND ANTIGOUT DRUGS ........................................................... 238
PART 9. IMMUNE AND BIOLOGICAL MODIFIERS AND CHEMOTHERAPEUTIC DRUGS ........................... 243
CHAPTER 50: IMMUNOSUPPRESSANT DRUGS .................................................................................... 243
CHAPTER 51: IMMUNIZING DRUGS AND PANDEMIC PREPAREDNESS ............................................... 247
CHAPTER 52: ANTINEOPLASTIC DRUGS PART 1: CANCER OVERVIEW AND CELL CYCLE–SPECIFIC
DRUGS................................................................................................................................................... 251
CHAPTER 53: ANTINEOPLASTIC DRUGS PART 2: CELL CYCLE–NONSPECIFIC AND MISCELLANEOUS
DRUGS................................................................................................................................................... 255

, CHAPTER 54: BIOLOGICAL RESPONSE–MODIFYING DRUGS AND ANTIRHEUMATIC DRUGS ............. 258
PART 10. MISCELLANEOUS THERAPEUTICS: HEMATOLOGICAL, DERMATOLOGICAL, OPHTHALMIC, AND
OTIC DRUGS .............................................................................................................................................. 262
CHAPTER 55: ANEMIA DRUGS.............................................................................................................. 262
CHAPTER 56: DERMATOLOGICAL DRUGS ............................................................................................ 266
CHAPTER 57: OPHTHALMIC DRUGS ..................................................................................................... 271
CHAPTER 58: OTIC DRUGS.................................................................................................................... 275

PART 1. PHARMACOLOGY BASICS
CHAPTER 01: NURSING PRACTICE IN CANADA AND DRUG THERAPY
SEALOCK: LILLEY’S PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE, 4TH EDITION

MULTIPLE CHOICE

1. WHICH IS A JUDGEMENT ABOUT A PARTICULAR PATIENT’S POTENTIAL NEED OR PROBLEM?

A. A GOAL

B. AN ASSESSMENT

C. SUBJECTIVE DATA

D. A NURSING DIAGNOSIS

ACCURATE ANS>>D

NURSING DIAGNOSIS IS THE PHASE OF THE NURSING PROCESS DURING WHICH A CLINICAL JUDGEMENT
IS MADE ABOUT HOW A PATIENT RESPONDS TO HEATH CONDITIONS AND LIFE PROCESSES OR
VULNERABILITY FOR THAT RESPONSE.

DIF: COGNITIVE LEVEL: KNOWLEDGE

2. THE PATIENT IS TO RECEIVE ORAL FUROSEMIDE (LASIX) EVERY DAY; HOWEVER, BECAUSE THE
PATIENT IS UNABLE TO SWALLOW, HE CANNOT TAKE MEDICATION ORALLY, AS ORDERED. THE NURSE
NEEDS TO CONTACT THE PHYSICIAN. WHAT TYPE OF PROBLEM IS THIS?

A. A “RIGHT TIME” PROBLEM

B. A “RIGHT DOSE” PROBLEM

C. A “RIGHT ROUTE” PROBLEM

D. A “RIGHT MEDICATION” PROBLEM

,ACCURATE ANS>>C

THIS IS A “RIGHT ROUTE” PROBLEM: THE NURSE CANNOT ASSUME THE ROUTE AND MUST CLARIFY THE
ROUTE WITH THE PRESCRIBER. THIS IS NOT A “RIGHT TIME” PROBLEM BECAUSE THE ORDERED
FREQUENCY HAS NOT CHANGED. THIS IS NOT A “RIGHT DOSE” PROBLEM BECAUSE THE DOSE IS NOT
RELATED TO AN INABILITY TO SWALLOW. THIS IS NOT A “RIGHT MEDICATION” PROBLEM BECAUSE THE
MEDICATION ORDERED WILL NOT CHANGE, JUST THE ROUTE.

DIF: COGNITIVE LEVEL: APPLICATION

3. THE NURSE HAS BEEN MONITORING THE PATIENT’S PROGRESS ON HIS NEW DRUG REGIMEN
SINCE THE FIRST DOSE AND HAS BEEN DOCUMENTING SIGNS OF POSSIBLE ADVERSE EFFECTS. WHAT
NURSING PROCESS PHASE IS THE NURSE PRACTISING?

A. PLANNING

B. EVALUATION

C. IMPLEMENTATION

D. NURSING DIAGNOSIS

ACCURATE ANS>>B

MONITORING THE PATIENT’S PROGRESS IS PART OF THE EVALUATION PHASE. PLANNING,
IMPLEMENTATION, AND NURSING DIAGNOSIS ARE NOT ILLUSTRATED BY THIS EXAMPLE.

DIF: COGNITIVE LEVEL: APPLICATION

4. THE NURSE IS CARING FOR A PATIENT WHO HAS BEEN NEWLY DIAGNOSED WITH TYPE 1
DIABETES MELLITUS. WHICH STATEMENT BEST ILLUSTRATES AN OUTCOME CRITERION FOR THIS
PATIENT?

A. THE PATIENT WILL FOLLOW INSTRUCTIONS.

B. THE PATIENT WILL NOT EXPERIENCE COMPLICATIONS.

C. THE PATIENT ADHERES TO THE NEW INSULIN TREATMENT REGIMEN.

D. THE PATIENT DEMONSTRATES SAFE INSULIN SELF-ADMINISTRATION TECHNIQUE.

ACCURATE ANS>>D

HAVING THE PATIENT DEMONSTRATE SAFE INSULIN SELF-ADMINISTRATION TECHNIQUE IS A SPECIFIC
AND MEASURABLE OUTCOME CRITERION. FOLLOWING INSTRUCTIONS AND AVOIDING COMPLICATIONS
ARE NOT SPECIFIC CRITERIA. ADHERENCE TO THE NEW INSULIN TREATMENT REGIMEN IS NOT
OBJECTIVE AND WOULD BE DIFFICULT TO MEASURE.

DIF: COGNITIVE LEVEL: APPLICATION

, 5. WHICH ACTIVITY BEST REFLECTS THE IMPLEMENTATION PHASE OF THE NURSING PROCESS FOR
THE PATIENT WHO IS NEWLY DIAGNOSED WITH TYPE 1 DIABETES MELLITUS?

A. PROVIDING EDUCATION REGARDING SELF-INJECTION TECHNIQUE

B. SETTING GOALS AND OUTCOME CRITERIA WITH THE PATIENT’S INPUT

C. RECORDING A HISTORY OF OVER-THE-COUNTER MEDICATIONS USED AT HOME

D. FORMULATING NURSING DIAGNOSES REGARDING KNOWLEDGE DEFICITS RELATED TO THE NEW
TREATMENT REGIMEN

ACCURATE ANS>>A

EDUCATION IS AN INTERVENTION THAT OCCURS DURING THE IMPLEMENTATION PHASE. SETTING
GOALS AND OUTCOME CRITERIA REFLECTS THE PLANNING PHASE. RECORDING A DRUG HISTORY
REFLECTS THE ASSESSMENT PHASE. FORMULATING NURSING DIAGNOSES REGARDING A KNOWLEDGE
DEFICIT REFLECTS ANALYSIS OF DATA AS PART OF THE PLANNING PHASE.

DIF: COGNITIVE LEVEL: ANALYSIS

6. THE NURSE IS WORKING DURING A VERY BUSY NIGHT SHIFT, AND THE HEALTH CARE PROVIDER
HAS JUST GIVEN THE NURSE A MEDICATION ORDER OVER THE TELEPHONE, BUT THE NURSE DOES NOT
RECALL THE ROUTE. WHAT IS THE BEST WAY FOR THE NURSE TO AVOID MEDICATION ERRORS?

A. RECOPY THE ORDER NEATLY ON THE ORDER SHEET, WITH THE MOST COMMON ROUTE
INDICATED

B. CONSULT WITH THE PHARMACIST FOR CLARIFICATION ABOUT THE MOST COMMON ROUTE

C. CALL THE HEALTH CARE PROVIDER TO CLARIFY THE ROUTE OF ADMINISTRATION

D. WITHHOLD THE DRUG UNTIL THE HEALTH CARE PROVIDER VISITS THE PATIENT

ACCURATE ANS>>C

IF A MEDICATION ORDER DOES NOT INCLUDE THE ROUTE, THE NURSE MUST ASK THE HEALTH CARE
PROVIDER TO CLARIFY IT. NEVER ASSUME THE ROUTE OF ADMINISTRATION.

DIF: COGNITIVE LEVEL: APPLICATION | COGNITIVE LEVEL: ANALYSIS

7. WHICH CONSTITUTES THE TRADITIONAL FIVE RIGHTS OF MEDICATION ADMINISTRATION?

A. RIGHT DRUG, RIGHT ROUTE, RIGHT DOSE, RIGHT TIME, AND RIGHT PATIENT

B. RIGHT DRUG, THE RIGHT EFFECT, THE RIGHT ROUTE, THE RIGHT TIME, AND THE RIGHT PATIENT

C. RIGHT PATIENT, RIGHT STRENGTH, RIGHT DIAGNOSIS, RIGHT DRUG, AND RIGHT ROUTE

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller NurseJanetteRichardson. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for CA$27.60. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

59063 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling

Exam (elaborations)

LILLEY'S PHARMACOLOGY FOR CANADIAN HEALTH CARE PRACTICE 4TH EDITION BY KARA SEALOCK|| COMPLETE TEST BANK GUIDE|| VERIFIED CHAPTERS INCLUDED WITH ACCURATE & ELABORATED ANSWERS|| NEWEST UPDATE|| 100% GURANTEED GUIDE

Document information

Subjects

Connected book

More summaries for

Written for

Seller

Reviews received

Content preview